Show simple item record

dc.contributor.authorGifre-Renom, Laia
dc.contributor.authorSeras-Franzoso, Joaquin
dc.contributor.authorRafael, Diana
dc.contributor.authorAndrade, Fernanda
dc.contributor.authorCano-Garrido, Olivia
dc.contributor.authorMartinez-Trucharte, Francesc
dc.contributor.authorUgarte-Berzal, Estefania
dc.contributor.authorMartens, Erik
dc.contributor.authorBoon, Lise
dc.contributor.authorVillaverde, Antonio
dc.contributor.authorOpdenakker, Ghislain
dc.contributor.authorSchwartz, Simó Jr.
dc.contributor.authorArís, Anna
dc.contributor.authorGarcia-Fruitós, Elena
dc.contributor.otherProducció Animalca
dc.date.accessioned2020-04-21T13:24:17Z
dc.date.available2020-04-21T13:24:17Z
dc.date.issued2020-02-15
dc.identifier.citationGifre-Renom, Laia, Joaquin Seras-Franzoso, Diana Rafael, Fernanda Andrade, Olivia Cano-Garrido, Francesc Martinez-Trucharte, and Estefania Ugarte-Berzal et al. 2020. "The Biological Potential Hidden In Inclusion Bodies". Pharmaceutics 12 (2): 157. MDPI AG. doi:10.3390/pharmaceutics12020157.ca
dc.identifier.issn1999-4923ca
dc.identifier.urihttp://hdl.handle.net/20.500.12327/733
dc.description.abstractInclusion bodies (IBs) are protein nanoclusters obtained during recombinant protein production processes, and several studies have demonstrated their potential as biomaterials for therapeutic protein delivery. Nevertheless, IBs have been, so far, exclusively sifted by their biological activity in vitro to be considered in further protein-based treatments in vivo. Matrix metalloproteinase-9 (MMP-9) protein, which has an important role facilitating the migration of immune cells, was used as model protein. The MMP-9 IBs were compared with their soluble counterpart and with MMP-9 encapsulated in polymeric-based micelles (PM) through ionic and covalent binding. The soluble MMP-9 and the MMP-9-ionic PM showed the highest activity values in vitro. IBs showed the lowest activity values in vitro, but the specific activity evolution in 50% bovine serum at room temperature proved that they were the most stable format. The data obtained with the use of an air-pouch mouse model showed that MMP-9 IBs presented the highest in vivo activity compared to the soluble MMP-9, which was associated only to a low and a transitory peak of activity. These results demonstrated that the in vivo performance is the addition of many parameters that did not always correlate with the in vitro behavior of the protein of interest, becoming especially relevant at evaluating the potential of IBs as a protein-based nanomaterial for therapeutic purposesca
dc.format.extent12ca
dc.language.isoengca
dc.publisherMDPIca
dc.relation.ispartofPharmaceuticsca
dc.rightsAttribution 4.0 Internationalca
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleThe biological potential hidden in inclusion bodiesca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.relation.projectIDINIA/Programa Nacional de Proyectos de Investigación Fundamental/RTA2012-00028-C02-01/ES/Optimización del periodo de secado de la vaca mediante nanopartículas proteicas/ca
dc.relation.projectIDINIA/Programa Estatal de I+D+I orientada a los retos de la Sociedad/RTA2015-00064-C02-01/ES/Validación del uso de las proteínas M-SAA3 y MMP-9 en la mejora del secado de la vaca de leche y optimización de su dosis efectiva mediante su nanoestructuración/ca
dc.subject.udc63ca
dc.identifier.doihttps://doi.org/10.3390/pharmaceutics12020157ca
dc.contributor.groupProducció de Remugantsca


Files in this item

 
 

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint